Foster City, CA, United States of America

Javier De Vicente Fidalgo

This inventor holds 35 USPTO granted patents and 27 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Kinase Inhibitors. Top assignees: Denali Therapeutics Inc., Roche Palo Alto LLC, Hoffmann-La Roche Inc.. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Javier De Vicente Fidalgo. Retrieved from https://idiyas.com/inventor/javier-de-vicente-fidalgo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 35 (Patent Applications = 27)

% Patents Active = 82.9

CIPO Patents = 1 (Patent Applications = 16)

EPO Patents = 9 (Patent Applications = 43)

Average Co-Inventor Count = 6.7

ph-index = 5

Forward Citations = 102(Granted Patents)

Location History:

Mountain View, CA (US) (2012)
Glen Ridge, NJ (US) (2011 - 2013)
South San Francisco, CA (US) (2021 - 2023)
Foster City, CA (US) (2014 - 2024)

Company Filing History:

27 out of 57

Denali Therapeutics Inc.

Hoffmann-La Roche Inc.

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

LRRK2 Inhibitors

Antiviral Compounds

Eukaryotic Initiation Factor

Bruton's Tyrosine Kinase

Substituted Pyrimidines

Isoxazolidine Inhibitors

Quinolone Derivatives

Heterocyclic Compounds

RIPK1 Inhibitors

JAK Inhibitors

HCV Polymerase Inhibitors

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747232 - Compounds, compositions, and methods (2026-09-29),

2. 12358928 - Compounds, compositions and methods (2025-07-15),

3. 12358896 - LRRK2 inhibitors and methods of making and using thereof (2025-07-15),

4. 12180211 - Compounds, compositions and methods (2024-12-31),

5. 12139478 - Compounds, compositions and methods (2024-11-12),

6. 12129263 - Kinase inhibitors and uses thereof (2024-10-29),

7. 12091392 - Compounds, compositions and methods (2024-09-17),

8. 11958840 - Compounds, compositions and methods (2024-04-16),

9. 11851440 - Modulators of eukaryotic initiation factor 2B, compositions and methods (2023-12-26),

10. 11851433 - Compounds, compositions and methods (2023-12-26),

11. 11840529 - Substituted pyrimidines as LRKK2 inhibitors (2023-12-12),

12. 11834439 - Compounds, compositions, and methods (2023-12-05),

13. 11591316 - Compounds, compositions, and methods (2023-02-28),

14. 11306077 - Compounds, compositions and methods (2022-04-19),

15. 11236100 - Modulators of eukaryotic initiation factor 2B, compositions and methods (2022-02-01),

Title: Inventor Spotlight: Javier de Vicente Fidalgo

Introduction:

Javier de Vicente Fidalgo is a prolific inventor based in Foster City, California, with an impressive portfolio of 24 patents to his name. His innovative work in the field of eukaryotic initiation factor 2B modulators has been making waves in the pharmaceutical industry.

Latest Patents:

Javier de Vicente Fidalgo's recent patents include groundbreaking inventions such as "Compounds, compositions and methods" and "Modulators of eukaryotic initiation factor 2B, compositions and methods." These patents focus on the development of eukaryotic initiation factor 2B modulators and their pharmaceutical applications.

Career Highlights:

Throughout his career, Javier de Vicente Fidalgo has made significant contributions to the field of biopharmaceuticals. He has worked with prestigious companies such as Denali Therapeutics Inc. and Roche Palo Alto LLC, where he has played a key role in developing innovative pharmaceutical products.

Collaborations:

In his professional journey, Javier de Vicente Fidalgo has collaborated with talented individuals such as Anthony A Estrada and Jianwen A Feng. Together, they have brought about groundbreaking advancements in the realm of eukaryotic initiation factor 2B modulators.

Conclusion:

Javier de Vicente Fidalgo's dedication to innovation and his remarkable ability to push the boundaries of pharmaceutical research have established him as a prominent figure in the industry. With a string of successful patents and a history of fruitful collaborations, he continues to inspire the next generation of inventors in the field.

Profile summary based on public USPTO records.